Our Strategy and Objectives
The “Digital Enterprise Innovations for Bioimaging, Biosensing and Biobanking Industries” project aims at promoting disruptive innovations in the medical diagnostic value chain by applying current digital technologies such as Artificial Intelligence.
The goal of the “Health Axis Europe Partnering” project is to facilitate international knowledge exchange between academia as well as small and medium-sized enterprises as innovators on the one side and global healthcare companies as innovation seekers on the other side.
The “Personalized Medicine Innovation through Digital Enterprise Solutions” project aims at providing key solutions for the reconfiguration of the biopharmaceutical value chain towards a Health Economy 4.0 with a special focus on oncology.
The German Federal Ministry of Education and Research (BMBF) and other project partners have joined forces to promote cancer research. Many stakeholders are involved in this 10-year program.